Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

New research elucidates details about architecture of synaptic transmission

For more than a century, neuroscientists have known that nerve cells talk to one another across the small gaps between them, a process known as synaptic transmission.

28 Jul 2016

New consensus statement recommends transition of care for adolescents with neurologic disorders

A new consensus statement provides recommendations for transitioning adolescents and young adults with neurologic disorders to adult care.

28 Jul 2016

Researchers identify new mechanisms capable of suppressing propagation of HCV

Researchers at Osaka University, Japan uncovered the mechanisms that suppress the propagation of the hepatitis C virus (HCV) with the potential of improving pathological liver conditions.

27 Jul 2016

Waterloo researchers unveil new screening tool and data at 2016 AAIC

Two studies involving University of Waterloo researchers presented this week at the 2016 Alzheimer's Association International Conference (AAIC) in Toronto highlight a new diagnostic tool that can identify Alzheimer's disease long before the onset of symptoms as well as the increasing prevalence of Alzheimer's disease in Ontario.

27 Jul 2016

Study examines efficacy of two treatments for mild cognitive impairment

A randomized controlled study has evaluated the effects of two treatments for mild cognitive impairment.

27 Jul 2016

Researchers discover pathway linking oxidative stress and cysteine in Huntington's disease

Researchers at Johns Hopkins Medicine report they have identified a biochemical pathway linking oxidative stress and the amino acid cysteine in Huntington's disease.

27 Jul 2016

Odor identification test may help detect early-stage Alzheimer's disease

Researchers from Columbia University Medical Center, New York State Psychiatric Institute, and NewYork-Presbyterian reported that an odor identification test may prove useful in predicting cognitive decline and detecting early-stage Alzheimer's disease.

26 Jul 2016

First confirmed case of Alzheimer’s disease in HIV-positive patient to be presented at AAIC 2016

The first case of Alzheimer's disease diagnosed in an HIV-positive individual will be presented in a poster session at the Alzheimer's Association International Conference 2016 in Toronto July 27.

26 Jul 2016

New research could provide insights into Alzheimer's and schizophrenia

Researchers comparing mouse and macaque brains have found evidence of an evolutionary universal brain structure in mammals that enables comparisons of cortical networks between species.

26 Jul 2016

Embryonic stem cell gene Nanog holds potential for reversing effects of aging

The fountain of youth may reside in an embryonic stem cell gene named Nanog.

26 Jul 2016

Good ceramides in skin creams and shampoos may hold promise for Alzheimer's treatment

The best-selling lipid in the world, often prominently featured on skin cream and shampoo labels, appears to also hold promise for Alzheimer's treatment, scientists say.

25 Jul 2016

Duke to lead early-stage clinical trials for promising new neurological therapies

Duke University could receive up to $19 million to lead early-stage clinical trials for new drugs to treat neurological conditions such as Alzheimer's disease and neuropathy.

22 Jul 2016

New neuroprotective compounds may prevent development of epilepsy

A team led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of LSU Health New Orleans' Neuroscience Center of Excellence, has developed neuroprotective compounds that may prevent the development of epilepsy.

22 Jul 2016

New protein may help scientists understand role of Abeta in Alzheimer's disease

A new protein which will help scientists to understand why nerve cells die in people with Alzheimer's disease has been designed in a University of Sussex laboratory.

22 Jul 2016

Cinnamon treatment turns poor-learning mice into good ones, research shows

If Dr. Kalipada Pahan's research pans out, the standard advice for failing students might one day be: Study harder and eat your cinnamon!

22 Jul 2016

Long-term antibiotic treatment slows progression of Alzheimer's disease through changes in gut bacteria

Long-term treatment with broad spectrum antibiotics decreased levels of amyloid plaques, a hallmark of Alzheimer's disease, and activated inflammatory microglial cells in the brains of mice in a new study by neuroscientists from the University of Chicago.

21 Jul 2016

TSRI study reveals new approach to intervene in deadly disease

In a new study, scientists at The Scripps Research Institute have identified drug candidates that can boost a cell's ability to catch the "typos" in protein production that can cause a deadly disease called amyloidosis.

From Paxman 21 Jul 2016

NYU Langone launches Alzheimer's and Related Dementias Family Support Program for caregivers

Two new grants from the New York State Department of Health will enable New Yorkers with Alzheimer's diseaseand dementia, and their families, to get the most comprehensive care and support services available in the New York City area.

20 Jul 2016

Discriminating remembrance may be marker for early stages of memory loss in older adults

People who selectively recalled positive information over neutral and negative information performed worse on memory tests conducted by University of California, Irvine neurobiologists, who said the results suggest that this discriminating remembrance may be a marker for early stages of memory loss in the elderly.

20 Jul 2016

New study of fMRI aims to develop efficient real-time method to detect brain activation in AD patients

Researchers at University Hospitals Case Medical Center are beginning a study of functional magnetic resonance imaging (fMRI) to detect how brain activation in patients in early and middle stages of Alzheimer's disease compares to people without it.

20 Jul 2016

Alzheimer's Disease News and Research

Further Reading

New research elucidates details about architecture of synaptic transmission

New consensus statement recommends transition of care for adolescents with neurologic disorders

Researchers identify new mechanisms capable of suppressing propagation of HCV

Waterloo researchers unveil new screening tool and data at 2016 AAIC

Study examines efficacy of two treatments for mild cognitive impairment

Researchers discover pathway linking oxidative stress and cysteine in Huntington's disease

Odor identification test may help detect early-stage Alzheimer's disease

First confirmed case of Alzheimer’s disease in HIV-positive patient to be presented at AAIC 2016

New research could provide insights into Alzheimer's and schizophrenia

Embryonic stem cell gene Nanog holds potential for reversing effects of aging

Good ceramides in skin creams and shampoos may hold promise for Alzheimer's treatment

Duke to lead early-stage clinical trials for promising new neurological therapies

New neuroprotective compounds may prevent development of epilepsy

New protein may help scientists understand role of Abeta in Alzheimer's disease

Cinnamon treatment turns poor-learning mice into good ones, research shows

Long-term antibiotic treatment slows progression of Alzheimer's disease through changes in gut bacteria

TSRI study reveals new approach to intervene in deadly disease

NYU Langone launches Alzheimer's and Related Dementias Family Support Program for caregivers

Discriminating remembrance may be marker for early stages of memory loss in older adults

New study of fMRI aims to develop efficient real-time method to detect brain activation in AD patients

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News